A recent study assessed the effectiveness of guideline-recommended therapies for Parkinson disease patients, including physiotherapy and occupational therapy.
The FDA has approved new options for lower limb spasticity, relapsed multiple myeloma, and diabetic foot ulcers that healthcare professionals should be aware of.
Investigators involved in the ongoing Parkinson’s Progression Markers Initiative study are aiming to define biomarkers of Parkinson disease diagnosis and progression. Here is what their latest analysis...
Researchers found that approximately 1 in 7 patients with aquaporin-4 antibody positive (AQP4-IgG+) neuromyelitis optica spectrum disorder (NMOSD) experienced neurologic symptoms before their first attack.
...
